Torrent Pharmaceuticals Limited (TORNTPHARM) — Financial Results
· NSE
Neutral
📢 Key Event
Trading window closure announced
💡 Investor Takeaway
Trading restrictions apply until quarterly results are filed.
Torrent Pharmaceuticals announced that its designated persons' trading window closes on 1 July 2026 and reopens 48 hours after submitting Q1 results for June 30, 2026.
About Torrent Pharmaceuticals Limited (TORNTPHARM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹1,49,108.91 Cr
P/E: 80.1
Recent Announcements from Torrent Pharmaceuticals Limited
-
🔴 Financial Results — 23 June 2026
Torrent Pharmaceuticals held its 53rd Annual General Meeting on 23 June 2026, approving standalone and consolidated financial statements for the year ... -
🔴 Announcement — 5 June 2026
No summary available -
🔴 Annual Report — 3 June 2026
Torrent Pharmaceuticals disclosed that shareholders with unregistered email addresses received a notice providing a web link to access the 53rd Annual... -
🔴 Annual Report — 1 June 2026
Torrent Pharmaceuticals Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 along with an Independent Reason... -
🔴 Corporate Action — 22 May 2026
Torrent Pharmaceuticals proposed a final dividend of ₹9 per share (180% payout) on a ₹5 face value, subject to shareholder approval at the upcoming AG...
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when TORNTPHARM files new disclosures
Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track TORNTPHARM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research